BSECompany Update29 Jul 2026 · 29 Jul 2026, 07:24 pm
Allotment of 21,47,665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation, 2015.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryFundraise
Venmax Drugs and Pharmaceuticals Ltd has allotted 21,47,665 equity shares to 8 warrant holders on a preferential basis, increasing the company's paid-up capital to Rs. 13,73,05,950.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment3/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Allotment